Reduction of 75% in the Psoriasis Area and Severity Index (PASI) for Moderate-to-Severe Psoriasis Vulgaris

Nahrisyah Nahrisyah; Kristo A. Nababan

doi:10.71197/jsocmed.v4i2.195

Reduction of 75% in the Psoriasis Area and Severity Index (PASI) for Moderate-to-Severe Psoriasis Vulgaris

Nahrisyah Nahrisyah
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Sumatera Utara
Kristo A. Nababan
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Sumatera Utara

Abstract

Introduction: Psoriasis vulgaris is a chronic inflammatory skin disorder characterized by the presence of scaly, red plaques. The severity of the condition is often evaluated using the Psoriasis Area and Severity Index (PASI), which quantifies the extent and severity of skin lesions. A treatment is considered successful when a PASI 75 is achieved, indicating a 75% reduction in the PASI score.

Case: A 26-year-old female presented with itchy and scaly red plaques covering nearly her entire body for the past month. Upon examination, her initial PASI score was 21.8. The patient was treated with a combination of systemic and topical therapies, resulting in a significant clinical improvement. Within two months, the patient achieved a PASI 75, demonstrating a 75% reduction in the PASI score.

Conclusion: This case underscores the importance of achieving PASI 75 as a critical treatment goal in both clinical practice and research. It highlights the potential of effective therapy in managing psoriasis vulgaris and serves as a guide for dermatologists in optimizing treatment strategies for psoriasis patient.

Similar Articles

Gio Justisia Batubara , Refli Hasan , Ali Nafiah Nasution , Harris Hasan, Anggia Chairuddin Lubis, Cut Aryfa Andra, Risk Factor–Weighted Clinical Probability for Predicting Obstructive Coronary Artery Disease in Patients Presenting with Unstable Angina , Journal of Society Medicine: Vol. 5 No. 3 (2026): March
Clarisa Monica, Taufik Sungkar, Ilhamd, Correlation between Helicobacter Pylori Caga Antibody Serum and Gastric Premalignant Lesions in Helicobacter Pylori Patients , Journal of Society Medicine: Vol. 2 No. 10 (2023): October
Nengah Darmawan, Amira Permatasari Tarigan, Andika Pradana, Relationship Between Asthma Therapy Types, Pulmonary Function, and Asthma Control in Primary Healthcare Facilities in Medan , Journal of Society Medicine: Vol. 4 No. 2 (2025): February
Fatima Bello, Chinedu Okafor, Gut Microbiota–Driven Modulation of Host Immune Responses in Severe Infections: Mechanistic Insights and Translational Implications , Journal of Society Medicine: Vol. 5 No. 3 (2026): March
Kadek Adi Sudarmika, Ni Luh Eka Sriayu Wulandari, Dilated Cardiomyopathy Related to Hyperthyroidism in Young Adults , Journal of Society Medicine: Vol. 3 No. 8 (2024): August
Dean Reza Purnama , Julyta Aliah, Indra Indra , Hemoperitoneum in Pregnancy: A Case Series and Clinical Management Insights , Journal of Society Medicine: Vol. 4 No. 8 (2025): August
Utama Hadiputra Surbakti, R.A. Dwi Pujiastuti, Kiking Ritarwan, Associations between Depression and Anxiety with Sleep Quality in Post Stroke Patients , Journal of Society Medicine: Vol. 2 No. 3 (2023): March
Dalimunthe Dina A, Sisilia K Dewi, Cutaneous Disorder Associated Diabetes Mellitus , Journal of Society Medicine: Vol. 4 No. 1 (2025): January
Azwar Iwan Tona , Pharmacologic Management of Hypertensive Disorders of Pregnancy and Postpartum Hypertension: Current Evidence and Clinical Implications , Journal of Society Medicine: Vol. 5 No. 2 (2026): February
Jessica Patricia Pangaribuan, Santi Syafril, Dian Anindita Lubis, Rahmad Isnanta, Imelda Rey, Effect of Glycemic Parameters on Mortality of Type 2 Diabetes Mellitus Patients with COVID-19 Infection in Haji Adam Malik Hospital Medan , Journal of Society Medicine: Vol. 2 No. 8 (2023): August

<< < 3 4 5 6 7 8 9 10 11 12 > >>

You may also start an advanced similarity search for this article.

PDF

Published at

28. February 2025
https://doi.org/10.71197/jsocmed.v4i2.195
Issue:

Vol. 4 No. 2 (2025): February
Section:

Articles
Keywords:

Psoriasis vulgaris Psoriasis area and severity index Treatment strategies
References:

Van de Kerkhof PCM, Nestle FO. Psoriasis. In: Bolognia JL, Schaffer JV, Cerroni L, editors. Dermatology. Elsevier. 2018; pp. 494-508.

Gudjonsson JE, Elder JT. Psoriasis. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, Orringer JS, editors. Fitzpatrick's Dermatology. 9th ed. New York: McGraw-Hill Education. 2019; pp. 457-497.

Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: A review. JAMA. 2020; 323(19): 1945-1960.

Burden AD, Kirby B. Psoriasis and related disorders. In: Rook’s Textbook of Dermatology. 9th ed. 2016; pp. 1–64.

Petit RG, Cano A, Ortiz A, Espina M, Prat J, Muñoz M, et al. Psoriasis: From pathogenesis to pharmacological and nano-technological-based therapeutics. Int J Mol Sci. 2021; 22(1): 150.

Yamanaka K, Yamamoto O, Honda T. Pathophysiology of psoriasis: A review. J Dermatol. 2021; 48(6): 722-731.

Hanani NK, Ervianti E, Rahniayu A. Clinical profile of psoriasis vulgaris at Soetomo General Hospital, Surabaya. Health Nations. 2020; 4(9): 282-289.

Damayanti, Pratiwi KD, Nugroho WT. Profile of psoriasis vulgaris patients treated with methotrexate at Dr. Soetomo Hospital, Surabaya, 2017-2018. Jurnal Berkala Epidemiologi. 2021; 9(1): 70-78.

Naufal A, Damayanti, Kusumastuti EH, Hidayati AN. Risk factor profile and quality of life of psoriasis vulgaris. Periodical of Dermatology and Venereology. 2021; 33(2): 129-134.

Listiawan MY, Fadila A, Wiratama PA, et al. Evaluation of histopathology findings of clinically confirmed psoriasis vulgaris. Berk Ilmu Kesehat Kulit Kelamin. 2023; 35: 21-26.

Negrutiu M, Danescu S, Popa T, Focsan M, Vesa SC, Szasz F, et al. Imaging approach in the diagnostics and evaluation of the psoriasis plaque: A preliminary study and literature review. Diagnostics. 2024; 14(10): 969.

Susanto PM. Tatalaksana psoriasis eritroderma. Jurnal Medika Hutama. 2022; 03(02): 45-50.

Foley P, Gebauer K, Sullivan J, McMeniman E, Shumack S, Ng J, James A, et al. Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies—Adult patients. Australas J Dermatol. 2023; 64(4): 476-487.

Manchanda Y, De A, Das S, Chakraborty D. Disease assessment in psoriasis. Indian J Dermatol. 2023; 68(3): 278-281.

Kamiya K, Kishimoto M, Sungai J, Komine M, Ohtsuki M. Risk factors for the development of psoriasis. Int J Mol Sci. 2019; 20(1): 1-14.

Perdoski. Psoriasis. In: Widaty S, Soebono H, Nilasari H, Listiawan MY, Siswati AS, Triwahyudi D, et al., editors. Panduan Praktik Klinis bagi Dokter Spesialis Kulit dan Kelamin di Indonesia. Jakarta. 2022; pp. 230-241.

Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019; 20(6): 1475.

Abrouk M, Nakamura M, Zhu TH, Farahnik B, Koo J, Bhutani T. The impact of PASI 75 and PASI 90 on quality of life in moderate to severe psoriasis patients. J Dermatolog Treat. 2017; 28(6): 488-491.

Kurniawan K, Fahira A, Ramadan ET, Budianti WK. Low-calorie diet improves PASI score in psoriasis patients with obesity: An evidence-based case report. J Gen Proced Dermatol Venereol Indones. 2021; 5(3): 193-203.

Ramic L, Sator P. Topical treatment of psoriasis vulgaris. J Dtsch Dermatol Ges. 2023; 21(6): 631-642.
Share:

Z

Nahrisyah, N., & Nababan, K. A. (2025). Reduction of 75% in the Psoriasis Area and Severity Index (PASI) for Moderate-to-Severe Psoriasis Vulgaris. Journal of Society Medicine, 4(2), 50–54. https://doi.org/10.71197/jsocmed.v4i2.195